Matthew Allen Walker serves as Executive at GreenLight Biosciences Holdings, PBC, where they oversee executive responsibilities. Since joining the company, Matthew Allen Walker has executed 4 insider transactions totaling $25.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 24, 2023 involved selling 63,775 shares valued at $0.
Matthew Allen Walker currently holds 63,775 shares of GreenLight Biosciences Holdings, PBC (GRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Allen Walker has been a net buyer of GRNA stock. They have purchased $25.2M and sold $0 worth of shares.
Matthew Allen Walker's most recent insider trade was on Jul 24, 2023, when they sold 63,775 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 11, 2022 | GRNA | $250.0K | Purchase | 63,775 | $3.92 | Discretionary |
| Aug 11, 2022 | GRNA | $25.0M | Purchase | 6,377,551 | $3.92 | Discretionary |